Vident Advisory’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $488K | Buy |
8,883
+2,837
| +47% | +$156K | 0.01% | 1067 |
|
|
2025
Q1 | $427K | Buy |
+6,046
| New | +$427K | 0.01% | 1118 |
|
|
2024
Q3 | – | Sell |
-2,877
| Closed | -$237K | – | 1434 |
|
|
2024
Q2 | $237K | Buy |
2,877
+160
| +6% | +$13.2K | 0.01% | 1214 |
|
|
2024
Q1 | $237K | Buy |
2,717
+14
| +0.5% | +$1.22K | ﹤0.01% | 1136 |
|
|
2023
Q4 | $261K | Buy |
2,703
+231
| +9% | +$22.3K | 0.01% | 1066 |
|
|
2023
Q3 | $219K | Buy |
+2,472
| New | +$219K | 0.01% | 1064 |
|